Sabra Healthcare REIT, Inc. $SBRA Stock: VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stake

VIRGINIA RETIREMENT SYSTEMS ET Al lowered its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 25.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 230,053 shares of the real estate investment trust’s stock after selling 79,800 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Sabra Healthcare REIT were worth $4,537,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in SBRA. Nissay Asset Management Corp Japan raised its holdings in Sabra Healthcare REIT by 1.5% in the 2nd quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock valued at $760,000 after buying an additional 585 shares during the last quarter. Versant Capital Management Inc boosted its position in Sabra Healthcare REIT by 70.0% during the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 603 shares during the period. GAMMA Investing LLC boosted its position in Sabra Healthcare REIT by 7.9% during the 3rd quarter. GAMMA Investing LLC now owns 9,927 shares of the real estate investment trust’s stock worth $196,000 after buying an additional 724 shares during the period. Anchor Investment Management LLC grew its holdings in Sabra Healthcare REIT by 17.8% during the 2nd quarter. Anchor Investment Management LLC now owns 4,877 shares of the real estate investment trust’s stock worth $95,000 after acquiring an additional 737 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in Sabra Healthcare REIT by 21.0% during the 1st quarter. EverSource Wealth Advisors LLC now owns 4,708 shares of the real estate investment trust’s stock worth $91,000 after acquiring an additional 817 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on SBRA shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. UBS Group cut their price target on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Citizens Jmp boosted their price objective on shares of Sabra Healthcare REIT from $23.00 to $25.00 and gave the stock a “market outperform” rating in a research note on Wednesday, July 22nd. Weiss Ratings downgraded Sabra Healthcare REIT from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Finally, Raymond James Financial raised Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $21.50.

Sabra Healthcare REIT Stock Performance

SBRA opened at $19.74 on Monday. Sabra Healthcare REIT, Inc. has a twelve month low of $17.27 and a twelve month high of $22.77. The company has a fifty day moving average of $19.87 and a 200-day moving average of $19.96. The stock has a market cap of $5.04 billion, a PE ratio of 75.93, a price-to-earnings-growth ratio of 1.79 and a beta of 0.63. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by ($0.27). The firm had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. Sabra Healthcare REIT’s quarterly revenue was up 24.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.38 EPS. On average, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current year.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.